About DecisionRx
DecisionRx is a company based in Indianapolis (United States) founded in 2022 by Brad Bostic. The company has 11 employees as of December 31, 2024. DecisionRx offers products and services including DecisionRx Kit and DecisionRx Report. DecisionRx operates in a competitive market with competitors including House Rx, Eurekam, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.
- Headquarter Indianapolis, United States
- Employees 11 as on 31 Dec, 2024
- Founders Brad Bostic
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Decision Rx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$100 M (USD), Debt – Conventional
Jan 11, 2024
- Investors
-
Employee Count
11
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DecisionRx
DecisionRx offers a comprehensive portfolio of products and services, including DecisionRx Kit and DecisionRx Report.
Kit for genetic analysis to optimize medication choices and reduce risks.
Report providing insights on medication effectiveness based on genetics.
People of DecisionRx
Unlock access to complete
Funding Insights of DecisionRx
Investors in DecisionRx
DecisionRx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Carlyle Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for DecisionRx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DecisionRx
Investment portfolio details for DecisionRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DecisionRx
Detailed financials for DecisionRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Decisionrx Comparisons
Peer comparison for DecisionRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DecisionRx
DecisionRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, Eurekam, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology-based medication solutions are provided for patients and caregivers.
|
|
| Locked | Locked | Locked |
AI-based medication management solutions for oncology professionals are provided.
|
|
| Locked | Locked | Locked |
Medication safety risk management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
|
|
| Locked | Locked | Locked |
DNA testing platform for user medication responses is offered.
|
Detailed competitors of DecisionRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Decisionrx
Complete news archive for DecisionRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DecisionRx
DecisionRx was founded in 2022 and raised its 1st funding round 2 years after it was founded.
DecisionRx is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
James Wallace is the current CEO of DecisionRx.
As of Dec 31, 2024, the latest employee count at DecisionRx is 11.
DecisionRx was founded in 2022 in Indianapolis, United States, as a provider in the healthcare sector focused on medication management. Solutions are offered that integrate Medication Therapy Management (MTM), PharmacoGenomics (PGx), and clinical lab data to support precise prescribing decisions informed by genetics, lab results, and patient life factors. Services target both patients and healthcare providers to enhance medication oversight and outcomes.
DecisionRx offers DecisionRx Kit and DecisionRx Report.
DecisionRx has 1 investor. Key investors include The Carlyle Group.